§ Federal grant opportunity · PAR-28-057
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed). The deadline is May 25, 2027 and the published award range is $500K.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- May 25, 2027
- Award range
- $500K
- Eligibility
- nonprofits non higher education with 501c3, state governments, small businesses, public and indian housing authorities, private institutions of higher education, other, independent school districts, nonprofits non higher education without 501c3, city or township governments, county governments, federally recognized native american tribal governments, other native american tribal organizations, for profit organizations other than small businesses, public and state institutions of higher education, special district governments
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-28-057
Program overview
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is soliciting applications for the establishment of the Management and Data Coordination Unit (MDCU), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC). The PCDC will continue to address one of the four research priorities identified in the National Cancer Institute's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma and conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify those patients who are at high risk of progression to cancer. The PCDC-MDCU will provide support towards collaborative efforts such as study design, protocol development, statistical analysis, coordination and data management. Other PCDC-MDCU activities include: coordination and support towards biorepository building; and organizational and logistics support for PCDC activities.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before May 25, 2027, allowing time for registration and validation.
Related grant opportunities
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)
- NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)
- U.S.-Africa Strategic Investment Program
- U.S.-Africa Strategic Investment Program
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.